The New York Times ran an article this week on a clinical trial being conducted on people “genetically guaranteed to develop” Alzheimer’s for a treatment that could stop the disease before it ever strikes your brain. Few trials have ever been run to test preventative treatments for “genetically predestined diseases” — and never before has there been one for Alzheimer’s. The study will pull most of its subjects from an extended family in Colombia — a clan of about 5,000 related people. Some of the members of this familial group show a clear genetic mutation linking to the development of Alzheimer’s starting with impaired (0 comments)